Is There a Role for Brachytherapy in High Risk Prostate Cancer?

Posted by Mira Keyes, MD, FRCPC | Aug 2016

Dr. Mira Keyes spoke at the 21st Annual Scottsdale Prostate Cancer Symposium on Sunday, March 13, 2016, on “Is There a Role for Brachytherapy in High Risk Prostate Cancer?”

Keywords: high risk prostate cancer, brachytherapy, ADT, EBRT, PSA

How to cite: Keyes, Mira. “Is There a Role for Brachytherapy in High Risk Prostate Cancer” Grand Rounds in Urology. March 12, 2016. Accessed Apr 2024. https://grandroundsinurology.com/brachytherapy-high-risk-prostate-cancer.

About The Author

Mira Keyes, MD, FRCPC

Dr. Mira Keyes is a Clinical Professor at the University of British Columbia (UBC) and a radiation oncologist at the Vancouver Centre of the British Columbia Cancer Agency (BCCA). She has also been the Head of the BCCA Prostate Brachytherapy Program since 2007. Dr. Keyes is one of the four founders of the Provincial BCCA Prostate Brachytherapy Program. She served as a Prostate Brachytherapy Program Quality Assurance Chair from 2003-2007, and as a UBC Radiation Oncology Residency Training Program Director from June 2001 to June 2006. From 2007-2012, she was a member of the Royal College of Physicians and Surgeons of Canada Examination Board in Radiation Oncology. From 2006-2009, she served as a UBC-BCCA Research Ethics Board Member. She is a member of BCCA provincial GU and Breast Tumour Groups. Her research interests include prostate brachytherapy outcomes, quality assurance, and translational research. She has been an invited speaker for CARO (Canadian Association of Radiation Oncology), CBG (Canadian Brachytherapy Group), ASTRO (American Society for Therapeutic Radiation Oncology), ABS (American Brachytherapy Society), and the Seattle Prostate Institute Advanced Brachytherapy Course.